Last week in @CDCMMWR: Global routine #vaccination coverage, rubella, and #opioid reports

Monday, November 20, 2017

Last week's edition of MMWR featured two global health-focused articles. The one that caught my eye was an update on coverage of routine vaccinations for children around the world. While progress has been substantial since the WHO launched the Expanded Program on Immunization in 1974, it appears to have stalled in the last few years:
Since then, global coverage with vaccines to prevent tuberculosis, diphtheria, tetanus, pertussis, poliomyelitis, and measles has increased from less than 5% to 85% or greater and additional vaccines against hepatitis B, Haemophilus influenzae type B, Streptococcus pneumoniae, rotavirus, and rubella have been included in vaccine recommendations introduced in multiple countries.
...
Global coverage with the third dose of diphtheria and tetanus toxoids and pertussis–containing vaccine, the third dose of polio vaccine, and first dose of measles- containing vaccine coverage has remained unchanged at 84%–86% since 2010. Among new or underused vaccines, global coverage increased during 2010–2016 for completed vaccine series against rotavirus (8% to 25%), Streptococcus pneumoniae (11% to 42%), rubella (35% to 47%), Haemophilus influenzae type B (42% to 70%) and hepatitis B vaccine (74% to 84%).
There is also an article on the progress of rubella elimination worldwide. As of December 2016, " Elimination of rubella and congenital rubella syndrome was verified in the WHO Region of the Americas in 2015, and 33 (62%) of 53 countries in the European Region have now eliminated endemic rubella and congenital rubella syndrome."

Bonus: The journal has compiled a list of all articles and reports on opioids published since 2000.

No comments :

Post a Comment